Aurora’s previous acquisition strategy has seen them initiate takeovers once the production facility is 80% complete (see H2 Biopharma and Peloton Pharmaceuticals). If they stick to that strategy then a takeover would eventuate in 4-6 months, depending on the speed of development.
CAN Price at posting:
$2.94 Sentiment: Buy Disclosure: Held
